Boy With aHUS Due to Rare Mutation Responded Well to Soliris, Report Finds

Boy With aHUS Due to Rare Mutation Responded Well to Soliris, Report Finds

294554

Boy With aHUS Due to Rare Mutation Responded Well to Soliris, Report Finds

A child with atypical hemolytic uremic syndrome (aHUS) caused by a mutation in the DGKE gene and with low levels of complement C3 — suggesting complement system dysregulation — responded well to treatment with Soliris (eculizumab), a case study reported. This case highlights the need for clinical trials that define a proper management protocol for people with these rarer forms of aHUS, its scientists noted. The case study, “A patient with a homozygous diacylglycerol kinase…

You must be logged in to read/download the full post.